0024-5918 : Dupixent 200 mg/1.14ml Subcutaneous Injection, Solution


NDC0024-5918
Labeler: Sanofi-aventis U.S. LLC
Product Type: Human Prescription Drug
Drug Name:  Dupixent
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761055
Rev. Date: 


NDC Package Codes:

  • 0024-5918-01: 2 SYRINGE, GLASS IN 1 CARTON (0024‑5918‑01) > 1.14 ML IN 1 SYRINGE, GLASS
  • 0024-5918-02: 2 SYRINGE, GLASS IN 1 CARTON (0024‑5918‑02) > 1.14 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Dupilumab

Dosage Strength:

  • 200 mg/1.14mL

Pharmaceutical Classes:

  • Interleukin-4 Receptor alpha Antagonist [EPC]
  • Interleukin 4 Receptor alpha Antagonists [MoA]
  • Antibodies
  • Monoclonal [CS]

Related Products:

Based on records with the same trade name.
  • 0024-5911 Dupixent 100 mg/.67ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5914 Dupixent 300 mg/2ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5915 Dupixent 300 mg/2ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5916 Dupixent 300 mg/2ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5919 Dupixent 200 mg/1.14ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0024-5918 QR Code

< Prev: 0024-5917Next: 0024-5919 >




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.